OCULAR THERAPEUTIX, INC
Recent Filings
All 817 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| 8-K | FORM 8-K | Feb 27, 2026 |
| 4 | OWNERSHIP DOCUMENT | Feb 25, 2026 |
| 4 | OWNERSHIP DOCUMENT | Feb 25, 2026 |
| 4 | OWNERSHIP DOCUMENT | Feb 25, 2026 |
| 4 | OWNERSHIP DOCUMENT | Feb 25, 2026 |
| 4 | OWNERSHIP DOCUMENT | Feb 24, 2026 |
| 4 | OWNERSHIP DOCUMENT | Feb 24, 2026 |
| 144 | — | Feb 23, 2026 |
| 144 | — | Feb 23, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Date |
|---|---|---|---|---|
| Dugel Pravin | See Remarks | Sale | 19,530 @ $12.04 | Nov 26, 2025 |
| Nayak Sanjay | Chief Strategy Officer | Sale | 1,878 @ $12.04 | Nov 24, 2025 |
| Kaiser Peter | Chief Development Officer | Sale | 3,007 @ $12.02 | Nov 24, 2025 |
| Heier Jeffrey S. | Chief Scientific Officer | Sale | 3,469 @ $12.04 | Nov 24, 2025 |
| Saroj Namrata | Chief Business Officer | Sale | 25,865 @ $10.74 | Nov 5, 2025 |
| Anderman Todd | Chief Legal Officer | Sale | 11,132 @ $12.34 | Oct 8, 2025 |
| Kaiser Peter | Chief Development Officer | Sale | 9,653 @ $11.03 | Oct 2, 2025 |
| Heier Jeffrey S. | Chief Scientific Officer | Sale | 10,502 @ $11.04 | Oct 2, 2025 |
| Notman Donald | See Remarks | Sale | 1,066 @ $12.43 | Sep 2, 2025 |
| Kaiser Peter | Chief Development Officer | Sale | 3,011 @ $12.04 | Aug 25, 2025 |